Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Axis, Be The Match, Biomica, Bristol Myers Squibb, Bryologyx, Cerus, Citius, Dynavax, Evogene, Fujitsu, Gamida, Iksuda, Immunitybio, Iontas, Medigen, Nanthealth, Nantomics, Neogene, Novecite, Novellus, Oncimmune, Ono, Oxford, Peptidream, Pharmaessentia, Portage, Regulus, Salvarx, Sanofi, Sidero, Silo, SK, Sorrento, SRS, Takeda, Twist, Vaxil, Windmil.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Algernon, Boehringer, Cytrx, Evelo, Gossamer, Humanigen, J&J, Lineage Cell, Mesoblast, Moleculin, Nabriva, Nanobiotix, Nasus, Neurorx, Regeneron, Relief, Sanofi, Targovax, Uniqure, Vaxart.

Biopharmas raising money in public or private financings, including: Abivax, Cedilla, Evotec, Jaguar, Kanaph, Lassogen, Regenerx.

New hires and promotions in the biopharma industry, including: Agenus, Aro, Evox, F4, Inozyme, Inversago, Larimar, Maxcyte, Neubase, Nitrome, Oxurion, Recode, VBL.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ac Immune, Alliance Family of Companies, Applied DNA Sciences, Battelle, Caretaker Medical, Cerner, Clinical Laserthermia Systems, Columbia University, DNA Labs International, Freedom Innovations, Haliodx, Induction, Medalliance, OSU Wexner Medical Center, Osmind, Ottobock, Pacific Edge, Paltown Development Foundation Proteor, Providence, Southwest Labs, Stratus, Tegria, Thermo Fisher Scientific, Votis.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Cartiheal, GE Healthcare, Varian.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences, Livanova, Lunit, Masimo.

New hires and promotions in the med-tech industry, including: Ambu, Brainomix.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alexion, Avenue, Astrazeneca, Celltrion, Gannex, Immunomedics, Oncopeptides, Oxular.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Altimmune, Antengene, Auravax, Bausch, Cstone, Curon, Eyenovia, Hitgen, Innocan, Ligand, Novabay, Pfizer, Rhizen, Wuxi.